OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-IL23/12 agents and JAK inhibitors for inflammatory bowel disease
Zhezhe Tian, Qiaorui Zhao, Xiu Teng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Zhezhe Tian, Qiaorui Zhao, Xiu Teng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Showing 7 citing articles:
Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta-analysis
Yafang Li, Jin Ding, Chong Lu, et al.
Acta Pharmaceutica (2025)
Open Access
Yafang Li, Jin Ding, Chong Lu, et al.
Acta Pharmaceutica (2025)
Open Access
Exploring the role of CD13 and inflammatory factors in radiation enteritis: insights from high-throughput proteomics and Mendelian randomization analysis
Xue Ren, Feng Shang, Defu Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Xue Ren, Feng Shang, Defu Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Identification of potential novel targets for treating inflammatory bowel disease using Mendelian randomization analysis
Ji‐Chang Fan, Yuan Lü, Jin‐Heng Gan, et al.
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Ji‐Chang Fan, Yuan Lü, Jin‐Heng Gan, et al.
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Advances in the research of intestinal fungi in Crohn's disease
Mo-Wei Kong, Yu Yang, Peng Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4318-4323
Closed Access | Times Cited: 1
Mo-Wei Kong, Yu Yang, Peng Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4318-4323
Closed Access | Times Cited: 1
Multi‐Omics Biomarkers for Predicting Efficacy of Biologic and Small‐Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review
L. Chen, Chuhan Zhang, Rui Niu, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
L. Chen, Chuhan Zhang, Rui Niu, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
Key Interleukins in Inflammatory Bowel Disease—A Review of Recent Studies
David Aebisher, Dorota Bartusik‐Aebisher, Agnieszka Przygórzewska, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 121-121
Open Access | Times Cited: 1
David Aebisher, Dorota Bartusik‐Aebisher, Agnieszka Przygórzewska, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 121-121
Open Access | Times Cited: 1
Mirikizumab – a new option in treatment of inflammatory bowel diseases
Jakub Olszewski, Katarzyna Kozon, Magdalena Sitnik, et al.
Prospects in Pharmaceutical Sciences (2024) Vol. 22, Iss. 3, pp. 178-185
Open Access
Jakub Olszewski, Katarzyna Kozon, Magdalena Sitnik, et al.
Prospects in Pharmaceutical Sciences (2024) Vol. 22, Iss. 3, pp. 178-185
Open Access
